Status:
TERMINATED
Evaluation of Intestinal Bacterial and Fungal Translocation and Intestinal Microbiota in Febrile Neutropenic Patients in Pediatric Onco-hematology
Lead Sponsor:
Centre Hospitalier Universitaire de Nīmes
Conditions:
Febrile Neutropenia
Eligibility:
All Genders
Up to 20 years
Brief Summary
This pilot study aims to study intestinal bacterial and fungal translocation and the evolution of the intestinal microbiota in patients over the course of their medical surveillance to search for a li...
Eligibility Criteria
Inclusion
- Information concerning the study set-up, objectives, constraints and the patient's rights is transmitted
- The patient and/or their legal guardian must have given their free and informed consent. If the patient is over 18, it is the patient who signs the consent form
- The patient must be a member or beneficiary of a health insurance plan
Exclusion
- The patient is under state guardianship or safeguard of justice
- Refusal to sign the consent
- It is impossible to give the subject informed information
- Pregnant, parturient or breast feeding patient
Key Trial Info
Start Date :
April 13 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 29 2018
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03342365
Start Date
April 13 2018
End Date
December 29 2018
Last Update
January 6 2021
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
UFR de Pharmacie Laboratoire de Parasitologie et Mycologie Médicale
Montpellier, France, 34093
2
CHU de Montpellier
Montpellier, France, 342995
3
CHU Nimes
Nîmes, France, 30029